Aducanumab Biosimilar - Research Grade

Aducanumab Biosimilar - Research Grade, His

Target: Amyloid Beta.

Specificity: Detects human Amyloid Beta. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Aducanumab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: RUO Aducanumab is a human monoclonal antibody that selectively targets aggregated amyloid beta. In a transgenic mouse model of Alzheimer’s disease, aducanumab is shown to enter the brain, bind parenchymal amyloid beta, and reduce soluble and insoluble amyloid beta in a dose-dependent manner.

Concentration: 5mg/ml.

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: >95% by SDS-PAGE.

Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• Artikelnummer: ICH5008-5MG
• Hersteller: Ichorbio
• Hersteller Artikelnummer: ICH5008-5MG
• Verpackungseinheit: 5mg
• Mengeneinheit: STK
• Reaktivität: Human
• Klonalität: Monoclonal
• Methode: Functional Assay
• Isotyp: His